The Group Room—the nationally syndicated radio call-in cancer talk show—aired a special lung cancer broadcast live from CHEST 2004, Sunday, Oct. 24, 2004. This special lung cancer broadcast was sponsored by The CHEST Foundation and addressed the latest detection and treatment advances in lung cancer and including an update on the ACCP Lung Cancer Guidelines released in 2003.
Live Remote Broadcast from CHEST 2004
Joining Selma R. Schimmel, Founder and CEO of Vital Options International, who is also the host of The Group Room, were the following:
-
W. Michael Alberts, MD, FCCP, Chief Medical Officer and Professor of Oncology and Medicine, University of South Florida College of Medicine, Tampa, Florida; Associate Center Director, Clinical Affairs, H. Lee Moffitt Cancer Center, Tampa, FL; and President Elect-designate, American College of Chest Physicians and Chair of the Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Guidelines Panel
-
Gerard Silvestri, MD, MS, FCCP, Associate Professor Of Medicine, Medical University Of South Carolina, Charleston, SC; Editor of the chapter on noninvasive staging in both the first and second editions of Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Guidelines; and also on the writing committees of both the screening chapter, and the invasive staging chapter.
-
M. Patricia Rivera, MD, FCCP, Assistant Professor of Medicine and Co-Director of Pulmonary/CCM; Co-Director, Multidisciplinary Thoracic Oncology Program; Co-Director, Pulmonary/Critical Care Fellowship Program University of North Carolina, Chapel Hill, NC; Editor of the chapter on diagnosis in the first edition of Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Guidelines; and now the chapter editor of Initial Evaluation & Diagnosis in the second edition of the Guidelines.
-
Walter Scott, MD, FCCP, Member and Attending Physician, Section of Thoracic Oncological Surgery, Fox Chase Cancer Center; Editor of the chapter on Treatment of Stage II NSCLC in the first edition of Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Guidelines; and now chapter editor of Treatment of Stage I and Stage II NSCLC in the second edition.
-
Howard (Jack) West, MD – Medical Oncologist, Swedish Cancer Institute, Seattle, Washington.